Winmill & CO. Inc. Makes New Investment in Nutex Health Inc. $NUTX

Winmill & CO. Inc. bought a new position in Nutex Health Inc. (NASDAQ:NUTX) during the second quarter, Holdings Channel reports. The firm bought 65,350 shares of the company’s stock, valued at approximately $11,168,000. Nutex Health makes up approximately 2.5% of Winmill & CO. Inc.’s investment portfolio, making the stock its 17th largest position.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in NUTX. BlackRock Inc. bought a new stake in Nutex Health in the 2nd quarter worth approximately $69,612,000. Pertento Partners LLP boosted its position in shares of Nutex Health by 20.0% during the 4th quarter. Pertento Partners LLP now owns 324,422 shares of the company’s stock valued at $53,406,000 after acquiring an additional 54,001 shares during the last quarter. Topline Capital Management LLC lifted its position in Nutex Health by 72.0% during the second quarter. Topline Capital Management LLC now owns 309,131 shares of the company’s stock valued at $38,484,000 after purchasing an additional 129,418 shares during the last quarter. Vanguard Group Inc. raised its position in shares of Nutex Health by 12.7% during the 3rd quarter. Vanguard Group Inc. now owns 214,954 shares of the company’s stock valued at $22,209,000 after buying an additional 24,275 shares in the last quarter. Finally, Millennium Management LLC grew its position in Nutex Health by 191.1% in the third quarter. Millennium Management LLC now owns 93,396 shares of the company’s stock worth $9,650,000 after acquiring an additional 61,308 shares in the last quarter. 5.32% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts have commented on the stock. B. Riley Financial started coverage on shares of Nutex Health in a research note on Friday, June 26th. They set a “buy” rating and a $290.00 price objective for the company. Wall Street Zen lowered Nutex Health from a “strong-buy” rating to a “buy” rating in a report on Monday, July 20th. Weiss Ratings raised Nutex Health from a “hold (c)” rating to a “hold (c+)” rating in a research note on Tuesday, July 28th. Zacks Research upgraded Nutex Health to a “hold” rating in a report on Monday, June 29th. Finally, Lake Street Capital reaffirmed a “buy” rating and set a $310.00 target price (up from $235.00) on shares of Nutex Health in a research report on Tuesday, August 11th. Three analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $268.33.

Nutex Health Price Performance

NASDAQ:NUTX opened at $185.84 on Monday. The company has a debt-to-equity ratio of 0.59, a current ratio of 5.00 and a quick ratio of 4.96. Nutex Health Inc. has a 1-year low of $77.21 and a 1-year high of $204.00. The company has a 50-day moving average of $167.30 and a 200 day moving average of $131.25. The firm has a market cap of $1.27 billion, a PE ratio of 7.30 and a beta of 0.24.

Nutex Health (NASDAQ:NUTX) last posted its earnings results on Thursday, August 6th. The company reported $9.38 EPS for the quarter, beating analysts’ consensus estimates of $4.95 by $4.43. Nutex Health had a net margin of 21.25% and a return on equity of 39.74%. The business had revenue of $210.75 million for the quarter, compared to the consensus estimate of $215.03 million. As a group, research analysts anticipate that Nutex Health Inc. will post 30.11 EPS for the current fiscal year.

About Nutex Health

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.